Do anticancer agents reach the tumor target in the human brain? M. G. DonelliM. ZucchettiM. D'Incalci Review Pages: 251 - 260
Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice William R. WaudJacqueline PlowmanDaniel P. Griswold Jr. Original Articles Pages: 261 - 266
Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin Roman Perez-SolerWaldemar Priebe Original Articles Pages: 267 - 271
Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas David C. SmithNicholas A. VickS. Clifford Schold Jr. Original Articles Pages: 272 - 276
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ Cai GrauJens Overgaard Original Articles Pages: 277 - 280
Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma Horng-Chyi ChangChyong-Huey LaiYung-Kuei Soong Original Articles Pages: 281 - 285
Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro Michael A. KolberPatricia Hill Original Articles Pages: 286 - 290
Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a cancer and leukemia group B study Jeffrey B. HargisJames R. AndersonDavid A. Van Echo Original Articles Pages: 291 - 296
A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions Howard BaileyGeorge WildingDavid R. Spriggs Original Articles Pages: 297 - 302
High-performance liquid chromatographic analysis of idarubicin and fluorescent metabolites in biological fluids Carlo M. CamaggiPatrizia CarisiFranco Pannuti Original Articles Pages: 303 - 306
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study Carlo M. CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 307 - 316
Renal handling of carboplatin Bente T. SørensenAnnette StrömgrenAnders Jakobsen Original Articles Pages: 317 - 320
Phase I trial of a 72-h continuous-infusion schedule of fazarabine Robert AmatoDah HoMartin Raber Original Articles Pages: 321 - 324
Benzamide potentiation of the cytotoxicity of bifunctional galacticol in resistant P388 leukemia correlates with inhibition of DNA ligase II Etel InstitorisBrian W. FoxIstván Pályi Original Articles Pages: 325 - 329
Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach N. B. TsavarisP. KomitsopoulouP. Kosmidis Short Communication Pages: 330 - 333